Nicolas Palaskas

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Nicolas Palaskas is an Assistant Professor at The University of Texas MD Anderson Cancer Center, located in the United States. His research focuses on cardio-oncology, with recent publications addressing topics such as immune checkpoint inhibitor-associated myocarditis, metastatic pericardial tumors, and cardiac dysfunction related to cancer treatments. He contributes to improving quality-of-care measures and risk stratification in cardiovascular complications associated with cancer therapeutics.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Demis Lipe

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Efstratios Koutroumpakis

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Lorenz Lehmann

Head of Cardio-Oncology Unit

University Hospital Heidelberg

GERMANY

View details

Adam Potter

Assistant Professor

UNITED STATES

View details

Teresa López-Fernández

La Paz University Hospital

SPAIN

View details

Dominique Monlezun

Professor (Adjunct Asst)

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicolas Palaskas

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Treating a Metastatic Pericardial Tumor

Immune checkpoint inhibitor-associated myocarditis: a novel risk score

Correlation of Natriuretic Peptides with Invasively Measured Intracardiac Filling Pressures in Patients With Cancer

Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction

Pacing Solutions for Immune Checkpoint Myocarditis and Associated Conduction Disorders

Quality-of-Care Measures for Cardio-Oncology

Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance

Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease

Immune checkpoint inhibitor-associated myocarditis: a review of current state of knowledge

Non-bacterial thrombotic endocarditis: a clinical and pathophysiological reappraisal

Kinase Inhibitors and Atrial Fibrillation

Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond Myocarditis

Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?

Cardiotoxicity associated with immune checkpoint inhibitors and CAR T-cell therapy

TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients

Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review.

Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management.

Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis.

Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy.

Cancer treatment resumption in patients with new-generation drug-eluting stents.

Collaborators (6)

Demis Lipe

Efstratios Koutroumpakis

Lorenz Lehmann

Adam Potter

Teresa López-Fernández

Dominique Monlezun

Make your next move.